β-Hydroxybutyrate Exacerbates Hypoxic Injury by Inhibiting HIF-1α-Dependent Glycolysis in Cardiomyocytes—Adding Fuel to the Fire? Xiurui MaZhen DongJunbo Ge Original Article Open access 15 October 2021 Pages: 383 - 397
Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis Xinghua PeiYanhong WuWu Lu Original Article 14 September 2021 Pages: 399 - 412
Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts Liqing WengLu LiXiangqing Kong Original Article 14 February 2022 Pages: 413 - 424
Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice Guangyan ZhangYin KangBradley B. Keller Original Article 14 February 2022 Pages: 425 - 436
SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis Xiyu ZhangCuiting ZhengYan Meng Original Article 14 July 2021 Pages: 437 - 447
The Association between Multi-Vessel Coronary Artery Disease and High On-Aspirin Platelet Reactivity Arthur ShiyovichLiat SassonLeor Perl Original Article 14 May 2021 Pages: 449 - 454
CD36+/CD61+ Microparticles Correlate with the Risk of Percutaneous Cardiac Interventions in Coronary Artery Disease Patients and the Effects of Ticagrelor Xue ZhouXing LiuJingjin Che Original Article 24 April 2021 Pages: 455 - 465
Impact of Calcium Channel Blockers on Aspirin Reactivity in Patients with Coronary Artery Disease Afek KodeshEli LevLeor Perl Original Article 20 November 2021 Pages: 467 - 473
Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease Paul MuntnerKate K. OrrothElizabeth A. Jackson Original Article 04 March 2021 Pages: 475 - 481
Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19 Laurent ChouchanaNathanaël Beekeron behalf of AP-HP/Universities/Inserm COVID-19 research collaboration, AP-HP Covid CDR Initiative, and “Entrepôt de Données de Santé” AP-HP Consortium” Short Communication 17 February 2021 Pages: 483 - 488
The Effect of Tafamidis on Circulating Endothelial Progenitor Cells in Patients with Transthyretin Cardiac Amyloidosis Osnat Itzhaki Ben ZadokDorit Leshem-LevAlon Eisen Original Article 22 September 2021 Pages: 489 - 496
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure Felix HoferNiema KazemAlexander Niessner Original Article 03 August 2021 Pages: 497 - 504
Rationale and Design of the ADIDAS Study: Association Between Dapagliflozin-Induced Improvement and Anemia in Heart Failure Patients Jianping ZengYunlong ZhuYingchun Wang Trial Designs Open access 29 March 2021 Pages: 505 - 509
The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review Qinchao WuBaochen BaiXianming Chu Review Article 13 April 2021 Pages: 511 - 524
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era Mahmoud AllahhamA. LermanY. Birnbaum Review Article 10 July 2021 Pages: 525 - 532
Efficacy and Safety of the Fixed-Dose Versus Variable-Dose of 4-PCC for Vitamin K Antagonist Reversal: A Comprehensive Systematic Review and Meta-Analysis Keyhan MohammadiShakila YaribashAzita Hajhossein Talasaz Review Article 17 April 2021 Pages: 533 - 546
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Pedro CastroMarta PalomoMaribel Diaz-Ricart Review Article 07 June 2021 Pages: 547 - 560
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus Bertram PittGabriel StegDeepak L. Bhatt Review Article Open access 09 November 2021 Pages: 561 - 567
Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins Tomoyuki Kawada Letter to the Editor 12 November 2021 Pages: 569 - 570
Letter to the Editor Regarding “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus” Yafei XieXiaowei Zhang Letter to the Editor 24 January 2022 Pages: 571 - 572
Response to the Letter on “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus” Bertram PittGabriel StegDeepak L. Bhatt Letter to the Editor 10 January 2022 Pages: 573 - 573
